Tuesday, September 16, 2025
The Latest Medical News
A Summary of The Latest Medical News: Two existing cancer drugs — letrozole and irinotecan — have shown **potential to reverse brain changes caused by Alzheimer’s disease** in mouse models[1][2].
**
**How the Research Was Done**
Scientists at UCSF and Gladstone Institutes first studied how Alzheimer’s disease changes gene activity in different brain cells, like neurons and glia. They then searched for **FDA-approved drugs that could reverse those specific gene changes**[2].
**
**Identifying Promising Drug Candidates**
Out of numerous possibilities, **letrozole (a breast cancer drug) and irinotecan (a colon and lung cancer drug) stood out** for their effects in reversing gene expression linked with Alzheimer’s in neurons and glia, respectively[1][2].
**
**What Happened in Mouse Models**
Giving mice either drug alone did not have a strong impact on the accumulation of tau protein clumps, which are a hallmark of Alzheimer’s. However, **when the drugs were used together, the results were dramatic**. The **combination reduced toxic tau clumps, lessened brain degeneration, and improved memory and learning in the affected animals**[1][2].
**
**Why a Combination Works**
The researchers explained that **Alzheimer’s disrupts many genes and proteins**, so a single drug is usually insufficient. By targeting both neurons and glia with two drugs, they could fight the disease’s complexity more effectively[1][2].
**
**From Laboratory to Potential Treatment**
While these results are promising, both letrozole and irinotecan have significant side effects, and they were only tested in mice so far. **Clinical trials in humans** are needed to see if this drug combination can help Alzheimer’s patients safely and effectively[1][2].
**
**A New Approach for Alzheimer’s**
Researchers are hopeful that their **computational approach — using big data to match drugs with precise brain changes — could offer more personalized and effective therapies for Alzheimer’s and similar diseases**[2].
**
**What’s Next**
If these findings translate to humans, millions of people living with Alzheimer’s could potentially benefit from this new drug combination. The hope is that **clinical trials will be launched soon to test the safety and effectiveness of letrozole and irinotecan in Alzheimer’s patients**[1][2].
Help with your insurance? https://tally.so/r/n012P9
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment